# DoD PRMRP Clinical Trial Award

Source: https://welltoldgrants.com/grants/w81xwh-22-prmrp-cta-dod-prmrp-clinical-trial-award/  
Official notice: https://www.grants.gov/search-results-detail/338721

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 8 awards worth $52.0 million in total. Applications closed on August 12, 2022.

| Field | Value |
|---|---|
| Opportunity number | W81XWH-22-PRMRP-CTA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | August 12, 2022 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 8 |
| Total funding | $52.0 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The FY22 PRMRP Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in one of the congressionally directed FY22 PRMRP Topic Areas and FY22 PRMRP Strategic Goals. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations. Funding from this award mechanism must support a clinical trial. A clinical trial is defined as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. For more information, a Human Subject Resource Document is provided at https://cdmrp.army.mil/pubs/pdf/Human%20Subjects%20Resource%20Document.pdf. Principal Investigators (PIs) seeking funding for a preclinical research project should consider one of the other FY22 PRMRP program announcements being offered. For information about these award mechanisms, see https://cdmrp.army.mil/funding/prmrp.

## Questions people ask

### Is W81XWH-22-PRMRP-CTA still open?

No. It closed on August 12, 2022. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD PRMRP Clinical Trial Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD PRMRP Clinical Trial Award?

Closed August 12, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $52.0 million in total across about 8 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.